Related Experiment Video
Updated: Aug 13, 2026

Minimal Erythema Dose (MED) Testing
Published on: May 28, 2013
Fixed drug eruption following metronidazole therapy and the use of topical provocation testing in diagnosis
K A Short1, L C Fuller, J R Salisbury
1Departments of Dermatology and Histopathology, King's College Hospital, London, UK. kshort@doctors.org.uk
Abstract:
Fixed drug eruption is characterized by recurrent well-defined lesions appearing in the same location each time the drug responsible is taken. A number of agents have been implicated. Metronidazole, a nitroimidazole agent widely used for its antibacterial and antiprotozoal activity, has been reported only rarely as the causative agent. We describe a patient with FDE due to metronidazole in whom we were able to induce the clinical and histological features of FDE by topical provocation testing. In agreement with the published literature we commend the use of topical provocation testing as a possible first-line investigation in the diagnosis of FDE. This may avoid the need for subsequent oral provocation testing and therefore the prevention of possible adverse sequelae.
Insights
Fixed drug eruption (FDE) is a rare reaction to metronidazole. Topical provocation testing successfully diagnosed metronidazole-induced FDE, confirming its utility in clinical practice.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Fixed drug eruption (FDE) is a specific type of adverse drug reaction.
- Metronidazole, an antibiotic and antiprotozoal agent, is infrequently implicated in FDE.
- Diagnosis of FDE often relies on identifying the causative agent.
Observation:
- A case of fixed drug eruption (FDE) attributed to metronidazole is presented.
- The patient exhibited characteristic FDE lesions upon re-exposure to the drug.
- Topical provocation testing was employed to elicit the FDE reaction.
Findings:
- Topical provocation testing successfully reproduced the clinical and histological features of metronidazole-induced FDE.
- This diagnostic method confirmed metronidazole as the causative agent in the described case.
- The findings align with existing literature suggesting metronidazole as a rare cause of FDE.
Implications:
- Topical provocation testing is a valuable diagnostic tool for fixed drug eruption (FDE).
- This method can potentially serve as a first-line investigation for FDE diagnosis.
- Utilizing topical testing may prevent the need for more invasive oral provocation, thus avoiding adverse events.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Allergic Drug Reactions
Drugs for Treatment of Ulcerative Colitis in IBD
Drug Toxicity: Allergic Reactions
Acne Infection

